November 12, 2015

Journal of Clinical Pathways Viewpoints

Overcoming the Political and Economic Roadblocks Stopping Effective Comparative Drug Evaluation

By Roger Longman

Transparent comparative evaluations are necessary for determining the relative value of drugs. But, in part because of resistance from drug companies and payers, stakeholders are finding other tools to help identify the appropriate choices.

read full article >